Cogent Biosciences, Inc. (COGT) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - COGT

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth171.20%

5Y CAGRN/A

10Y CAGR-2.46%

Equity

1Y Growth148.31%

5Y CAGR22.08%

10Y CAGR24.78%

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	-65.0%	-10.1%	-2.0%	21.4%	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	131.1%	64.1%	52.4%	N/A	N/A	N/A	N/A	N/A
FY 2018 Dec 31, 2018	16.4%	23.8%	48.3%	N/A	N/A	N/A	N/A	N/A
FY 2017 Dec 31, 2017	31.5%	67.3%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2016 Dec 31, 2016	112.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2015 Dec 31, 2015	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - COGT

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Cogent Biosciences, Inc.

Compare with peers

Explore

Growth Analysis - COGT

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Cogent Biosciences, Inc.

Compare with peers

Explore